Latest News and Press Releases

SEATTLE, WA--(Marketwired - Oct 31, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that the U.S. District Court for the Western District of Washington has granted the defendants'...

SEATTLE, WA--(Marketwired - Oct 22, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced it has received certification to Annex II of the European Medical Device Directive (MDD) from its...

SEATTLE, WA--(Marketwired - Oct 6, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 13th Annual BIO Investor...

SEATTLE, WA--(Marketwired - Sep 23, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that the U.S. Food and Drug Administration has issued a determination that the ForeCYTE Breast...

SEATTLE, WA--(Marketwired - Sep 4, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment...

SEATTLE, WA--(Marketwired - Sep 3, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has hired Scott Youmans as Senior Vice President of Operations effective September 2,...

SEATTLE, WA--(Marketwired - Sep 2, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc., or the NRLBH, will...

SEATTLE, WA--(Marketwired - Aug 28, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc., or the NRLBH, has...

SEATTLE, WA--(Marketwired - Aug 20, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has submitted additional information to the U.S. Food and Drug Administration in response to...

SEATTLE, WA--(Marketwired - Aug 12, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced Second Quarter 2014 financial results and provided an update on recent corporate developments. ...